References
- Song K, Han M, Cheong MY, Lim KS, Kim DK. Clinical research design and biostatistical methods. Korean J Urol 2005;46:835-841.
- Feinstein AR. Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials. J Clin Epidemiol 1989;42:481-489; discussion 499-502. https://doi.org/10.1016/0895-4356(89)90142-X
- Naylor CD, Guyatt GH. Users' guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services. The Evidence-Based Medicine Working Group. JAMA 1996;275:554-558. https://doi.org/10.1001/jama.1996.03530310060034
- Woo JM, Hyun SY, Lee SH, Kang SG, Lee JS, Kim L, et al. Productivity time lost by sleep disturbance among workers in Korea. J Korean Neuropsychiatr Assoc 2011;50:62-68.
- Fisher HL, Moffitt TE, Houts RM, Belsky DW, Arseneault L, Caspi A. Bullying victimisation and risk of self harm in early adolescence: longitudinal cohort study. BMJ 2012;344:e2683. https://doi.org/10.1136/bmj.e2683
- Zhang XY, Chen da C, Xiu MH, Haile CN, Sun H, Lu L, et al. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study. PLoS One 2012;7:e36563. https://doi.org/10.1371/journal.pone.0036563
- Ahn YM, Lee KY, Kim KS, Kim DK, Kim YH, Kim CY, et al. Body weight gain and metabolic changes in patients with schizophrenia during 12-week randomized treatment of ziprasidone and risperidone. Korean J Psychopharmacol 2007;18:92-102.
- Senn S. Cross-over Trials in Clinical Research. West Sussex: Wiley; 2002.
- Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 1999;56:29-36. https://doi.org/10.1001/archpsyc.56.1.29
- Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63:856-864. https://doi.org/10.1001/archpsyc.63.8.856
- Correll CU, Kishimoto T, Kane JM. Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives. Dialogues Clin Neurosci 2011;13:155-172.
- Hofer A, Hummer M, Huber R, Kurz M, Walch T, Fleischhacker WW. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol 2000;20:699-702. https://doi.org/10.1097/00004714-200012000-00019
- Niv N, Cohen AN, Hamilton A, Reist C, Young AS. Effectiveness of a Psychosocial Weight Management Program for Individuals with Schizophrenia. J Behav Health Serv Res 2012. [Epub ahead of print]
- Moller HJ. Effectiveness studies: advantages and disadvantages. Dialogues Clin Neurosci 2011;13:199-207.